{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T17:21:25Z","timestamp":1780420885049,"version":"3.54.1"},"reference-count":27,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100012411","name":"National Institute of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015250","name":"National Institute for Health Research Health Protection Research Unit","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015250","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalmicrobiologyandinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.cmi.2020.02.021","type":"journal-article","created":{"date-parts":[[2020,3,25]],"date-time":"2020-03-25T02:37:50Z","timestamp":1585103870000},"page":"1651-1657","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Evaluating the risk of hyperkalaemia and acute kidney injury with cotrimoxazole: a retrospective observational study"],"prefix":"10.1016","volume":"26","author":[{"given":"J.","family":"Rajput","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.S.P.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Mughal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmi.2020.02.021_bib1","author":"Wollaston"},{"key":"10.1016\/j.cmi.2020.02.021_bib2","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.ijantimicag.2016.11.020","article-title":"Old antibiotics for multidrug-resistant pathogens: from in\u00a0vitro activity to clinical outcomes","volume":"49","author":"Kaye","year":"2017","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.cmi.2020.02.021_bib3","doi-asserted-by":"crossref","first-page":"405","DOI":"10.2165\/00003088-198005050-00001","article-title":"Clinical pharmacokinetics of co-trimoxazole (trimethoprim\u2013sulphamethoxazole)","volume":"5","author":"Patel","year":"1980","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.cmi.2020.02.021_bib4","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1093\/clinids\/4.2.426","article-title":"Adverse reactions to trimethoprim\u2013sulfamethoxazole in hospitalized patients","volume":"4","author":"Jick","year":"1982","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2020.02.021_bib5","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1503\/cmaj.111152","article-title":"Considerations when prescribing trimethoprim\u2013sulfamethoxazole","volume":"183","author":"Ho","year":"2011","journal-title":"CMAJ"},{"key":"10.1016\/j.cmi.2020.02.021_bib6","doi-asserted-by":"crossref","first-page":"227","DOI":"10.2165\/00002018-200022030-00006","article-title":"Trimethoprim-induced hyperkalaemia\u2014clinical data, mechanism, prevention and management","volume":"22","author":"Perazella","year":"2000","journal-title":"Drug Saf"},{"key":"10.1016\/j.cmi.2020.02.021_bib7","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1177\/1060028013509973","article-title":"An evaluation of hyperkalemia and serum creatinine elevation associated with different dosage levels of outpatient trimethoprim\u2013sulfamethoxazole with and without concomitant medications","volume":"47","author":"Gentry","year":"2013","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.cmi.2020.02.021_bib8","first-page":"467","article-title":"Renal insufficiency in concert with renin\u2013angiotensin\u2013aldosterone inhibition is a major risk factor for hyperkalemia associated with low-dose trimethoprim\u2013sulfamethoxazole in adults","volume":"55","author":"Higashioka","year":"2016","journal-title":"J\u00a0Intern Med"},{"key":"10.1016\/j.cmi.2020.02.021_bib9","doi-asserted-by":"crossref","first-page":"pd5228","DOI":"10.1136\/bmj.d5228","article-title":"Trimethoprim\u2013sulfamethoxazole induced hyperkalaemia in elderly patients receiving spironolactone: nested case\u2013control study","volume":"343","author":"Antoniou","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.cmi.2020.02.021_bib10","doi-asserted-by":"crossref","first-page":"6196","DOI":"10.1136\/bmj.g6196","article-title":"Co-trimoxazole and sudden death in patients receiving inhibitors of renin\u2013angiotensin system: population based study","volume":"349","author":"Fralick","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/j.cmi.2020.02.021_bib11","first-page":"802","article-title":"Effect of trimethoprim\u2013sulfamethoxazole on the renal excretion of creatinine in man","volume":"114","author":"Berglund","year":"1975","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.cmi.2020.02.021_bib12","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/S0140-6736(78)90486-5","article-title":"Effect of co-trimoxazole on normal creatinine clearance","volume":"311","author":"Shouval","year":"1978","journal-title":"Lancet"},{"key":"10.1016\/j.cmi.2020.02.021_bib13","first-page":"221","article-title":"Co-trimoxazole, creatinine and renal function","volume":"2","author":"Trollfors","year":"1980","journal-title":"J\u00a0Infect"},{"key":"10.1016\/j.cmi.2020.02.021_bib14","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1093\/jac\/dks030","article-title":"Acute kidney injury associated with trimethoprim\/sulfamethoxazole","volume":"67","author":"Fraser","year":"2012","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2020.02.021_bib15","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1186\/s13054-016-1478-z","article-title":"Acute kidney injury 2016: diagnosis and diagnostic workup","volume":"20","author":"Ostermann","year":"2016","journal-title":"Crit Care"},{"key":"10.1016\/j.cmi.2020.02.021_bib16","first-page":"pc179","article-title":"KDIGO clinical practice guidelines for acute kidney injury","volume":"120","author":"Khwaja","year":"2012","journal-title":"Nephron"},{"key":"10.1016\/j.cmi.2020.02.021_bib17","doi-asserted-by":"crossref","first-page":"pR204","DOI":"10.1186\/cc2872","volume":"8","author":"Bellomo","year":"2004","journal-title":"Crit Care"},{"key":"10.1016\/j.cmi.2020.02.021_bib18","doi-asserted-by":"crossref","first-page":"pR31","DOI":"10.1186\/cc5713","article-title":"Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury","volume":"11","author":"Mehta","year":"2007","journal-title":"Crit Care"},{"key":"10.1016\/j.cmi.2020.02.021_bib19","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1007\/s00134-001-1120-6","article-title":"Acute renal failure: time for consensus","volume":"27","author":"Bellomo","year":"2001","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.cmi.2020.02.021_bib20","first-page":"85","article-title":"Acute kidney injury: definition, pathophysiology and clinical phenotypes","volume":"37","author":"Makris","year":"2016","journal-title":"Clin Biochem Rev"},{"key":"10.1016\/j.cmi.2020.02.021_bib21","doi-asserted-by":"crossref","first-page":"pe19","DOI":"10.1309\/LM920SBNZPJRJGUT","article-title":"Overview of urea and creatinine","volume":"45","author":"Salazar","year":"2014","journal-title":"Lab Med"},{"key":"10.1016\/j.cmi.2020.02.021_bib22","series-title":"Clinical methods: the history, physical, and laboratory examinations","first-page":"874","article-title":"BUN and creatinine","author":"Hosten","year":"1990"},{"key":"10.1016\/j.cmi.2020.02.021_bib23","first-page":"S1","article-title":"K\/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification","volume":"39","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.cmi.2020.02.021_bib24","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/ki.2008.107","article-title":"The risk of acute renal failure in patients with chronic kidney disease","volume":"74","author":"Hsu","year":"2008","journal-title":"Kidney Int"},{"key":"10.1016\/j.cmi.2020.02.021_bib25","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1001\/jama.2009.1322","article-title":"Chronic dialysis and death among survivors of acute kidney injury requiring dialysis","volume":"302","author":"Wald","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.cmi.2020.02.021_bib26","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.2215\/CJN.00830110","article-title":"Chronic kidney disease: an inherent risk factor for acute kidney injury?","volume":"5","author":"Singh","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.cmi.2020.02.021_bib27","first-page":"3","article-title":"Drug-induced acute interstitial nephritis: pathology, pathogenesis and treatment","volume":"9","author":"Krishnan","year":"2015","journal-title":"Iranian J Kidney Dis"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X2030104X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X2030104X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T07:27:13Z","timestamp":1761118033000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X2030104X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":27,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["S1198743X2030104X"],"URL":"https:\/\/doi.org\/10.1016\/j.cmi.2020.02.021","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluating the risk of hyperkalaemia and acute kidney injury with cotrimoxazole: a retrospective observational study","name":"articletitle","label":"Article Title"},{"value":"Clinical Microbiology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cmi.2020.02.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}